Wenzhen Duan

10.5k total citations · 1 hit paper
95 papers, 7.8k citations indexed

About

Wenzhen Duan is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Wenzhen Duan has authored 95 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cellular and Molecular Neuroscience, 39 papers in Molecular Biology and 28 papers in Neurology. Recurrent topics in Wenzhen Duan's work include Genetic Neurodegenerative Diseases (40 papers), Mitochondrial Function and Pathology (31 papers) and Neurological disorders and treatments (18 papers). Wenzhen Duan is often cited by papers focused on Genetic Neurodegenerative Diseases (40 papers), Mitochondrial Function and Pathology (31 papers) and Neurological disorders and treatments (18 papers). Wenzhen Duan collaborates with scholars based in United States, China and Germany. Wenzhen Duan's co-authors include Mark P. Mattson, Jaewon Lee, Zhihong Guo, Sic L. Chan, Christopher A. Ross, Haiyang Jiang, Peng Qi, Carsten Culmsee, Ward A. Pedersen and Mali Jiang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Wenzhen Duan

90 papers receiving 7.6k citations

Hit Papers

Evidence that brain‐derived neurotrophic factor is requir... 2002 2026 2010 2018 2002 250 500 750

Peers

Wenzhen Duan
Sic L. Chan United States
Roy G. Cutler United States
Paula C. Bickford United States
Eva Carro Spain
Thomas van Groen United States
Paul A. Adlard Australia
Sic L. Chan United States
Wenzhen Duan
Citations per year, relative to Wenzhen Duan Wenzhen Duan (= 1×) peers Sic L. Chan

Countries citing papers authored by Wenzhen Duan

Since Specialization
Citations

This map shows the geographic impact of Wenzhen Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenzhen Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenzhen Duan more than expected).

Fields of papers citing papers by Wenzhen Duan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenzhen Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenzhen Duan. The network helps show where Wenzhen Duan may publish in the future.

Co-authorship network of co-authors of Wenzhen Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Wenzhen Duan. A scholar is included among the top collaborators of Wenzhen Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenzhen Duan. Wenzhen Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Duan, Wenzhen. (2025). Alzheimers Disease: Pathological Mechanism and Treatment. Theoretical and Natural Science. 73(1). 53–63. 1 indexed citations
3.
Yang, Xiuli, Yuguo Li, Adnan Bibic, et al.. (2025). Vascular Microbleeds Without Brain Atrophy: A Microvascular Signature of Mid-Stage 5xFAD Pathology. bioRxiv (Cold Spring Harbor Laboratory).
4.
Wu, Qian, Hongshuai Liu, Chang Liu, et al.. (2025). Progressively reduced cerebral oxygen metabolism and elevated plasma NfL levels in the zQ175DN mouse model of Huntington's disease. Experimental Neurology. 394. 115461–115461.
5.
Duan, Wenzhen, et al.. (2025). The glymphatic system in Huntington's disease. Journal of Huntington s Disease. 14(3). 279–290.
6.
Wei, Zhiliang, Lida Du, Ruoxuan Li, et al.. (2024). Senolytic therapy preserves blood-brain barrier integrity and promotes microglia homeostasis in a tauopathy model. Neurobiology of Disease. 202. 106711–106711. 12 indexed citations
7.
Liu, Hongshuai, Andrea K. McCollum, Tamara Ratovitski, et al.. (2024). Roscovitine, a CDK Inhibitor, Reduced Neuronal Toxicity of mHTT by Targeting HTT Phosphorylation at S1181 and S1201 In Vitro. International Journal of Molecular Sciences. 25(22). 12315–12315. 1 indexed citations
8.
Li, Mingyue, Xueping Yu, Yuet Wai Kan, et al.. (2024). Baihui‐Penetrating‐Qubin Acupuncture Attenuates Neurological Deficits Through SIRT1/FOXO1 Reducing Oxidative Stress and Neuronal Apoptosis in Intracerebral Hemorrhage Rats. Brain and Behavior. 14(12). e70095–e70095. 1 indexed citations
9.
Smith, Edward J., Kirupa Sathasivam, Christian Landles, et al.. (2022). Early detection of exon 1 huntingtin aggregation in zQ175 brains by molecular and histological approaches. Brain Communications. 5(1). fcad010–fcad010. 19 indexed citations
10.
Morelli, Kathryn H., Qian Wu, Maya L. Gosztyla, et al.. (2022). An RNA-targeting CRISPR–Cas13d system alleviates disease-related phenotypes in Huntington’s disease models. Nature Neuroscience. 26(1). 27–38. 60 indexed citations
11.
Jiang, Mali, Peng Qi, Xinfeng Liu, et al.. (2013). Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington's disease. Human Molecular Genetics. 22(12). 2462–2470. 105 indexed citations
12.
Duan, Wenzhen. (2013). Sirtuins: from metabolic regulation to brain aging. Frontiers in Aging Neuroscience. 5. 36–36. 78 indexed citations
13.
Ratovitski, Tamara, Xiaofang Wang, Mali Jiang, et al.. (2012). Transgenic Mouse Model Expressing the Caspase 6 Fragment of Mutant Huntingtin. Journal of Neuroscience. 32(1). 183–193. 45 indexed citations
14.
Zhang, Xiang, Marta Valenza, Lei Cui, et al.. (2011). Peroxisome-Proliferator-Activated Receptor Gamma Coactivator 1   Contributes to Dysmyelination in Experimental Models of Huntington's Disease. Journal of Neuroscience. 31(26). 9544–9553. 110 indexed citations
15.
Jiang, Mali, Zhong Pei, Yong Cheng, et al.. (2010). Baicalein reduces E46K α‐synuclein aggregation in vitro and protects cells against E46K α‐synuclein toxicity in cell models of familiar Parkinsonism. Journal of Neurochemistry. 114(2). 419–429. 70 indexed citations
16.
Xu, X.Z. Shawn, Ming Zhan, Wenzhen Duan, et al.. (2007). Gene expression atlas of the mouse central nervous system: impact and interactions of age, energy intake and gender. Genome biology. 8(11). R234–R234. 80 indexed citations
17.
Mattson, Mark P., Wenzhen Duan, Jaewon Lee, et al.. (2001). Progress in the Development of Caloric Restriction Mimetic Dietary Supplements. 4(3). 225–232. 14 indexed citations
18.
Mattson, Mark P., Wenzhen Duan, Ward A. Pedersen, & Carsten Culmsee. (2001). Neurodegenerative disorders and ischemic brain diseases. APOPTOSIS. 6(1-2). 69–81. 260 indexed citations
19.
Begley, James G., Wenzhen Duan, Sic L. Chan, Karen Duff, & Mark P. Mattson. (1999). Altered Calcium Homeostasis and Mitochondrial Dysfunction in Cortical Synaptic Compartments of Presenilin‐1 Mutant Mice. Journal of Neurochemistry. 72(3). 1030–1039. 132 indexed citations
20.
Mattson, Mark P., Wenzhen Duan, Sic L. Chan, & Simonetta Camandola. (1999). Par-4: An Emerging Pivotal Player in Neuronal Apoptosis and Neurodegenerative Disorders. Journal of Molecular Neuroscience. 13(1-2). 17–30. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026